The global Animal Health Active Pharmaceutical Ingredients market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Animal Health Active Pharmaceutical Ingredients is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Animal Health Active Pharmaceutical Ingredients is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Animal Health Active Pharmaceutical Ingredients is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Animal Health Active Pharmaceutical Ingredients include Glenmark Pharmaceutical, Zoetis, Eli Lilly, Sanofi Winthrop Industrie, Indukern, P&R SpA (Olon SpA), Lonza Group, Huvepharma and Sequent Scientific, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Animal Health Active Pharmaceutical Ingredients, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Animal Health Active Pharmaceutical Ingredients, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Animal Health Active Pharmaceutical Ingredients, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Animal Health Active Pharmaceutical Ingredients sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Animal Health Active Pharmaceutical Ingredients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Animal Health Active Pharmaceutical Ingredients sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Glenmark Pharmaceutical, Zoetis, Eli Lilly, Sanofi Winthrop Industrie, Indukern, P&R SpA (Olon SpA), Lonza Group, Huvepharma and Sequent Scientific, etc.
By Company
Glenmark Pharmaceutical
Zoetis
Eli Lilly
Sanofi Winthrop Industrie
Indukern
P&R SpA (Olon SpA)
Lonza Group
Huvepharma
Sequent Scientific
NGL Fine Chem
Segment by Type
Antiparasitics
Anti-infectives
NSAIDs & Anesthetics
Others
Segment by Application
Pharmacy
Pet Hospital
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Animal Health Active Pharmaceutical Ingredients in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Animal Health Active Pharmaceutical Ingredients manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Health Active Pharmaceutical Ingredients sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Animal Health Active Pharmaceutical Ingredients Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antiparasitics
1.2.3 Anti-infectives
1.2.4 NSAIDs & Anesthetics
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmacy
1.3.3 Pet Hospital
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Animal Health Active Pharmaceutical Ingredients Sales Estimates and Forecasts 2018-2029
2.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Region
2.2.1 Global Animal Health Active Pharmaceutical Ingredients Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Region (2018-2023)
2.2.3 Global Animal Health Active Pharmaceutical Ingredients Revenue by Region (2024-2029)
2.2.4 Global Animal Health Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Region (2018-2029)
2.3 Global Animal Health Active Pharmaceutical Ingredients Sales Estimates and Forecasts 2018-2029
2.4 Global Animal Health Active Pharmaceutical Ingredients Sales by Region
2.4.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Animal Health Active Pharmaceutical Ingredients Sales by Region (2018-2023)
2.4.3 Global Animal Health Active Pharmaceutical Ingredients Sales by Region (2024-2029)
2.4.4 Global Animal Health Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Manufacturers
3.1.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Manufacturers (2018-2023)
3.1.2 Global Animal Health Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Animal Health Active Pharmaceutical Ingredients in 2022
3.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Manufacturers
3.2.1 Global Animal Health Active Pharmaceutical Ingredients Revenue by Manufacturers (2018-2023)
3.2.2 Global Animal Health Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Animal Health Active Pharmaceutical Ingredients Revenue in 2022
3.3 Global Key Players of Animal Health Active Pharmaceutical Ingredients, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Animal Health Active Pharmaceutical Ingredients Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Animal Health Active Pharmaceutical Ingredients 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Animal Health Active Pharmaceutical Ingredients, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Animal Health Active Pharmaceutical Ingredients, Product Offered and Application
3.8 Global Key Manufacturers of Animal Health Active Pharmaceutical Ingredients, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Type
4.1.1 Global Animal Health Active Pharmaceutical Ingredients Historical Sales by Type (2018-2023)
4.1.2 Global Animal Health Active Pharmaceutical Ingredients Forecasted Sales by Type (2024-2029)
4.1.3 Global Animal Health Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Type
4.2.1 Global Animal Health Active Pharmaceutical Ingredients Historical Revenue by Type (2018-2023)
4.2.2 Global Animal Health Active Pharmaceutical Ingredients Forecasted Revenue by Type (2024-2029)
4.2.3 Global Animal Health Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Animal Health Active Pharmaceutical Ingredients Price by Type
4.3.1 Global Animal Health Active Pharmaceutical Ingredients Price by Type (2018-2023)
4.3.2 Global Animal Health Active Pharmaceutical Ingredients Price Forecast by Type (2024-2029)
5 麻豆原创 Size by Application
5.1 Global Animal Health Active Pharmaceutical Ingredients Sales by Application
5.1.1 Global Animal Health Active Pharmaceutical Ingredients Historical Sales by Application (2018-2023)
5.1.2 Global Animal Health Active Pharmaceutical Ingredients Forecasted Sales by Application (2024-2029)
5.1.3 Global Animal Health Active Pharmaceutical Ingredients Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Animal Health Active Pharmaceutical Ingredients Revenue by Application
5.2.1 Global Animal Health Active Pharmaceutical Ingredients Historical Revenue by Application (2018-2023)
5.2.2 Global Animal Health Active Pharmaceutical Ingredients Forecasted Revenue by Application (2024-2029)
5.2.3 Global Animal Health Active Pharmaceutical Ingredients Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Animal Health Active Pharmaceutical Ingredients Price by Application
5.3.1 Global Animal Health Active Pharmaceutical Ingredients Price by Application (2018-2023)
5.3.2 Global Animal Health Active Pharmaceutical Ingredients Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Type
6.1.1 US & Canada Animal Health Active Pharmaceutical Ingredients Sales by Type (2018-2029)
6.1.2 US & Canada Animal Health Active Pharmaceutical Ingredients Revenue by Type (2018-2029)
6.2 US & Canada Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Application
6.2.1 US & Canada Animal Health Active Pharmaceutical Ingredients Sales by Application (2018-2029)
6.2.2 US & Canada Animal Health Active Pharmaceutical Ingredients Revenue by Application (2018-2029)
6.3 US & Canada Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Country
6.3.1 US & Canada Animal Health Active Pharmaceutical Ingredients Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Animal Health Active Pharmaceutical Ingredients Sales by Country (2018-2029)
6.3.3 US & Canada Animal Health Active Pharmaceutical Ingredients Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Type
7.1.1 Europe Animal Health Active Pharmaceutical Ingredients Sales by Type (2018-2029)
7.1.2 Europe Animal Health Active Pharmaceutical Ingredients Revenue by Type (2018-2029)
7.2 Europe Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Application
7.2.1 Europe Animal Health Active Pharmaceutical Ingredients Sales by Application (2018-2029)
7.2.2 Europe Animal Health Active Pharmaceutical Ingredients Revenue by Application (2018-2029)
7.3 Europe Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Country
7.3.1 Europe Animal Health Active Pharmaceutical Ingredients Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Animal Health Active Pharmaceutical Ingredients Sales by Country (2018-2029)
7.3.3 Europe Animal Health Active Pharmaceutical Ingredients Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size
8.1.1 China Animal Health Active Pharmaceutical Ingredients Sales (2018-2029)
8.1.2 China Animal Health Active Pharmaceutical Ingredients Revenue (2018-2029)
8.2 China Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Application
8.2.1 China Animal Health Active Pharmaceutical Ingredients Sales by Application (2018-2029)
8.2.2 China Animal Health Active Pharmaceutical Ingredients Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Type
9.1.1 Asia Animal Health Active Pharmaceutical Ingredients Sales by Type (2018-2029)
9.1.2 Asia Animal Health Active Pharmaceutical Ingredients Revenue by Type (2018-2029)
9.2 Asia Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Application
9.2.1 Asia Animal Health Active Pharmaceutical Ingredients Sales by Application (2018-2029)
9.2.2 Asia Animal Health Active Pharmaceutical Ingredients Revenue by Application (2018-2029)
9.3 Asia Animal Health Active Pharmaceutical Ingredients Sales by Region
9.3.1 Asia Animal Health Active Pharmaceutical Ingredients Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Animal Health Active Pharmaceutical Ingredients Revenue by Region (2018-2029)
9.3.3 Asia Animal Health Active Pharmaceutical Ingredients Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients Sales by Country
10.3.1 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Animal Health Active Pharmaceutical Ingredients Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Glenmark Pharmaceutical
11.1.1 Glenmark Pharmaceutical Company Information
11.1.2 Glenmark Pharmaceutical Overview
11.1.3 Glenmark Pharmaceutical Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Glenmark Pharmaceutical Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Glenmark Pharmaceutical Recent Developments
11.2 Zoetis
11.2.1 Zoetis Company Information
11.2.2 Zoetis Overview
11.2.3 Zoetis Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Zoetis Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zoetis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Eli Lilly Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Sanofi Winthrop Industrie
11.4.1 Sanofi Winthrop Industrie Company Information
11.4.2 Sanofi Winthrop Industrie Overview
11.4.3 Sanofi Winthrop Industrie Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Sanofi Winthrop Industrie Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Winthrop Industrie Recent Developments
11.5 Indukern
11.5.1 Indukern Company Information
11.5.2 Indukern Overview
11.5.3 Indukern Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Indukern Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Indukern Recent Developments
11.6 P&R SpA (Olon SpA)
11.6.1 P&R SpA (Olon SpA) Company Information
11.6.2 P&R SpA (Olon SpA) Overview
11.6.3 P&R SpA (Olon SpA) Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 P&R SpA (Olon SpA) Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 P&R SpA (Olon SpA) Recent Developments
11.7 Lonza Group
11.7.1 Lonza Group Company Information
11.7.2 Lonza Group Overview
11.7.3 Lonza Group Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Lonza Group Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lonza Group Recent Developments
11.8 Huvepharma
11.8.1 Huvepharma Company Information
11.8.2 Huvepharma Overview
11.8.3 Huvepharma Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Huvepharma Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Huvepharma Recent Developments
11.9 Sequent Scientific
11.9.1 Sequent Scientific Company Information
11.9.2 Sequent Scientific Overview
11.9.3 Sequent Scientific Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Sequent Scientific Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sequent Scientific Recent Developments
11.10 NGL Fine Chem
11.10.1 NGL Fine Chem Company Information
11.10.2 NGL Fine Chem Overview
11.10.3 NGL Fine Chem Animal Health Active Pharmaceutical Ingredients Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 NGL Fine Chem Animal Health Active Pharmaceutical Ingredients Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 NGL Fine Chem Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Animal Health Active Pharmaceutical Ingredients Industry Chain Analysis
12.2 Animal Health Active Pharmaceutical Ingredients Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Animal Health Active Pharmaceutical Ingredients Production Mode & Process
12.4 Animal Health Active Pharmaceutical Ingredients Sales and 麻豆原创ing
12.4.1 Animal Health Active Pharmaceutical Ingredients Sales Channels
12.4.2 Animal Health Active Pharmaceutical Ingredients Distributors
12.5 Animal Health Active Pharmaceutical Ingredients Customers
13 麻豆原创 Dynamics
13.1 Animal Health Active Pharmaceutical Ingredients Industry Trends
13.2 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Drivers
13.3 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Challenges
13.4 Animal Health Active Pharmaceutical Ingredients 麻豆原创 Restraints
14 Key Findings in The Global Animal Health Active Pharmaceutical Ingredients Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Glenmark Pharmaceutical
Zoetis
Eli Lilly
Sanofi Winthrop Industrie
Indukern
P&R SpA (Olon SpA)
Lonza Group
Huvepharma
Sequent Scientific
NGL Fine Chem
听
听
*If Applicable.